The M7e Series features five modules, and are the smallest UHF RFID modules on the market, enabling customers to use the chip in extremely small applications such as handheld RFID scanners, wearable RFID devices, surgical hand scanners, mobile RFID printers and smart vending machines. JADAK will work with healthcare OEMs, retailers, and CPG customers to integrate the module into unique applications worldwide.
In addition to the small size, the modules boast ultra-low power consumption, a necessary requirement for mobile RFID printers, handheld or battery-operated devices used in the retail and inventory tracking spaces. And, each module is capable of varying read rates to accommodate a wide variety of application needs.
One of the most unique features of the M7e Series, as well as all other ThingMagic modules from JADAK is obtaining certification for select countries in advance. JADAK has extensive expertise in regulatory certification and works to obtain these certifications prior to launch, easing the burden on OEMs to obtain their own regulatory certification.
Additional benefits to customers include accuracy, speed, and the ability to track consumer behaviors over time, allowing for inventory changes to better match customer expectations. And the entire M7e Series is also supported by ThingMagic Mercury API, a standardized API used across all ThingMagic products.
JADAK, a business unit of Novanta, is in machine vision, RFID, barcode, printing, and color and light measurement products and services for original equipment manufacturers. The business designs and manufactures automated identification and data collection solutions that help customers solve unique inspection, tracking, scanning and documenting challenges.
JADAK is based in Syracuse, New York, with sales and technical locations across the globe.
Novanta is a trusted technology partner to OEMs in the medical and advanced industrial technology markets, with deep proprietary expertise in photonics, vision, and precision motion technologies.
Brain+ launches Ayla CST Assistant following UK regulatory approval
Accelerate Diagnostics receives FDA clearance for automated blood culture system
Photocure's partner Asieris presents Cevira Phase III subgroup analysis at 2024 CSCO Annual Meeting
Boston Scientific's FARAPULSE Pulsed Field Ablation system receives Japanese regulatory approval
Implantica advances RefluxStop with CE mark study results and prepares for FDA submission
Arrowhead Pharmaceuticals seeks approval for ARO-INHBE obesity study
Nicox and Glaukos sign exclusive research and licensing option agreement
Creo Medical forms strategic partnership with Micro-Tech via EUR36.7m subsidiary sale
Epitomee Medical's Capsule cleared by FDA for weight management
Eurofins strengthens biopharma testing in US with Infinity Labs acquisition